Copyright Reports & Markets. All rights reserved.

Global Anti-Infective Treatment Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Anti-Infective Treatment Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Anti-Infective Treatment Market Size Growth Rate by Product
      • 1.4.2 OTC
      • 1.4.3 Rx Drugs
    • 1.5 Market by End User
      • 1.5.1 Global Anti-Infective Treatment Market Size Growth Rate by End User
      • 1.5.2 Hospital
      • 1.5.3 Drugs Store
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Anti-Infective Treatment Market Size
      • 2.1.1 Global Anti-Infective Treatment Revenue 2014-2025
      • 2.1.2 Global Anti-Infective Treatment Sales 2014-2025
    • 2.2 Anti-Infective Treatment Growth Rate by Regions
      • 2.2.1 Global Anti-Infective Treatment Sales by Regions
      • 2.2.2 Global Anti-Infective Treatment Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Anti-Infective Treatment Sales by Manufacturers
      • 3.1.1 Anti-Infective Treatment Sales by Manufacturers
      • 3.1.2 Anti-Infective Treatment Sales Market Share by Manufacturers
      • 3.1.3 Global Anti-Infective Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Anti-Infective Treatment Revenue by Manufacturers
      • 3.2.1 Anti-Infective Treatment Revenue by Manufacturers (2014-2019)
      • 3.2.2 Anti-Infective Treatment Revenue Share by Manufacturers (2014-2019)
    • 3.3 Anti-Infective Treatment Price by Manufacturers
    • 3.4 Anti-Infective Treatment Manufacturing Base Distribution, Product Types
      • 3.4.1 Anti-Infective Treatment Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Anti-Infective Treatment Product Type
      • 3.4.3 Date of International Manufacturers Enter into Anti-Infective Treatment Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Anti-Infective Treatment Sales by Product
    • 4.2 Global Anti-Infective Treatment Revenue by Product
    • 4.3 Anti-Infective Treatment Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Anti-Infective Treatment Breakdown Data by End User

    6 North America

    • 6.1 North America Anti-Infective Treatment by Countries
      • 6.1.1 North America Anti-Infective Treatment Sales by Countries
      • 6.1.2 North America Anti-Infective Treatment Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Anti-Infective Treatment by Product
    • 6.3 North America Anti-Infective Treatment by End User

    7 Europe

    • 7.1 Europe Anti-Infective Treatment by Countries
      • 7.1.1 Europe Anti-Infective Treatment Sales by Countries
      • 7.1.2 Europe Anti-Infective Treatment Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Anti-Infective Treatment by Product
    • 7.3 Europe Anti-Infective Treatment by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Anti-Infective Treatment by Countries
      • 8.1.1 Asia Pacific Anti-Infective Treatment Sales by Countries
      • 8.1.2 Asia Pacific Anti-Infective Treatment Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Anti-Infective Treatment by Product
    • 8.3 Asia Pacific Anti-Infective Treatment by End User

    9 Central & South America

    • 9.1 Central & South America Anti-Infective Treatment by Countries
      • 9.1.1 Central & South America Anti-Infective Treatment Sales by Countries
      • 9.1.2 Central & South America Anti-Infective Treatment Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Anti-Infective Treatment by Product
    • 9.3 Central & South America Anti-Infective Treatment by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Anti-Infective Treatment by Countries
      • 10.1.1 Middle East and Africa Anti-Infective Treatment Sales by Countries
      • 10.1.2 Middle East and Africa Anti-Infective Treatment Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Anti-Infective Treatment by Product
    • 10.3 Middle East and Africa Anti-Infective Treatment by End User

    11 Company Profiles

    • 11.1 GlaxoSmithKline
      • 11.1.1 GlaxoSmithKline Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 GlaxoSmithKline Anti-Infective Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 GlaxoSmithKline Anti-Infective Treatment Products Offered
      • 11.1.5 GlaxoSmithKline Recent Development
    • 11.2 Merck
      • 11.2.1 Merck Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Merck Anti-Infective Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Merck Anti-Infective Treatment Products Offered
      • 11.2.5 Merck Recent Development
    • 11.3 Pfizer
      • 11.3.1 Pfizer Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Pfizer Anti-Infective Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Pfizer Anti-Infective Treatment Products Offered
      • 11.3.5 Pfizer Recent Development
    • 11.4 Novartis AG
      • 11.4.1 Novartis AG Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Novartis AG Anti-Infective Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Novartis AG Anti-Infective Treatment Products Offered
      • 11.4.5 Novartis AG Recent Development
    • 11.5 Gilead Sciences
      • 11.5.1 Gilead Sciences Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Gilead Sciences Anti-Infective Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Gilead Sciences Anti-Infective Treatment Products Offered
      • 11.5.5 Gilead Sciences Recent Development
    • 11.6 Abbott
      • 11.6.1 Abbott Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Abbott Anti-Infective Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Abbott Anti-Infective Treatment Products Offered
      • 11.6.5 Abbott Recent Development
    • 11.7 Wyeth
      • 11.7.1 Wyeth Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Wyeth Anti-Infective Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Wyeth Anti-Infective Treatment Products Offered
      • 11.7.5 Wyeth Recent Development
    • 11.8 Sanofi-Aventis
      • 11.8.1 Sanofi-Aventis Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Sanofi-Aventis Anti-Infective Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Sanofi-Aventis Anti-Infective Treatment Products Offered
      • 11.8.5 Sanofi-Aventis Recent Development
    • 11.9 Bristol-Myers Squibb
      • 11.9.1 Bristol-Myers Squibb Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Bristol-Myers Squibb Anti-Infective Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Bristol-Myers Squibb Anti-Infective Treatment Products Offered
      • 11.9.5 Bristol-Myers Squibb Recent Development
    • 11.10 Johnson
      • 11.10.1 Johnson Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Johnson Anti-Infective Treatment Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Johnson Anti-Infective Treatment Products Offered
      • 11.10.5 Johnson Recent Development
    • 11.11 Roche Pharma AG
    • 11.12 Nanosphere
    • 11.13 NanoViricides
    • 11.14 Novabay Pharmaceuticals
    • 11.15 Obetech
    • 11.16 Optimer Pharmaceuticals
    • 11.17 Basilea Pharmaceutica AG
    • 11.18 Daiichi Sankyo
    • 11.19 MerLion Pharma
    • 11.20 Theravance

    12 Future Forecast

    • 12.1 Anti-Infective Treatment Market Forecast by Regions
      • 12.1.1 Global Anti-Infective Treatment Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Anti-Infective Treatment Revenue Forecast by Regions 2019-2025
    • 12.2 Anti-Infective Treatment Market Forecast by Product
      • 12.2.1 Global Anti-Infective Treatment Sales Forecast by Product 2019-2025
      • 12.2.2 Global Anti-Infective Treatment Revenue Forecast by Product 2019-2025
    • 12.3 Anti-Infective Treatment Market Forecast by End User
    • 12.4 North America Anti-Infective Treatment Forecast
    • 12.5 Europe Anti-Infective Treatment Forecast
    • 12.6 Asia Pacific Anti-Infective Treatment Forecast
    • 12.7 Central & South America Anti-Infective Treatment Forecast
    • 12.8 Middle East and Africa Anti-Infective Treatment Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Anti-Infective Treatment Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
      The global Anti-Infective Treatment market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Anti-Infective Treatment market based on company, product type, end user and key regions.

      This report studies the global market size of Anti-Infective Treatment in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Anti-Infective Treatment in these regions.
      This research report categorizes the global Anti-Infective Treatment market by top players/brands, region, type and end user. This report also studies the global Anti-Infective Treatment market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      GlaxoSmithKline
      Merck
      Pfizer
      Novartis AG
      Gilead Sciences
      Abbott
      Wyeth
      Sanofi-Aventis
      Bristol-Myers Squibb
      Johnson
      Roche Pharma AG
      Nanosphere
      NanoViricides
      Novabay Pharmaceuticals
      Obetech
      Optimer Pharmaceuticals
      Basilea Pharmaceutica AG
      Daiichi Sankyo
      MerLion Pharma
      Theravance

      Market size by Product
      OTC
      Rx Drugs
      Market size by End User
      Hospital
      Drugs Store
      Other

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Anti-Infective Treatment market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Anti-Infective Treatment market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Anti-Infective Treatment companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Anti-Infective Treatment submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Anti-Infective Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Anti-Infective Treatment market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now